Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumors

Citation
R. Konishi et al., Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumors, J DERMA SCI, 24(3), 2000, pp. 177-183
Citations number
28
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF DERMATOLOGICAL SCIENCE
ISSN journal
09231811 → ACNP
Volume
24
Issue
3
Year of publication
2000
Pages
177 - 183
Database
ISI
SICI code
0923-1811(200012)24:3<177:POPCKI>2.0.ZU;2-P
Abstract
Polymorphisms of the cyclin-dependent kinase inhibitor gene p21 have recent ly been reported to be associated with several human cancers. To determine whether the polymorphisms are also associated with human skin cancers, we i nvestigated the p21 polymorphisms in 165 healthy Japanese and 113 Japanese with malignant skin tumors: 30 squamous cell carcinoma, 20 malignant melano ma, 33 basal cell carcinoma, and 30 Bowen's disease. The p21 polymorphisms were characterized by single base substitutions in the following two sites: the last nucleotide of codon 31 of exon 2 and the site 20 nucleotides down stream from the 3' end of exon 3. The two polymorphic sites were reported t o be firmly linked to each other. We have shown that the two sites were fir mly linked to each other also in Japanese and that no associations of the p olymorphisms with the skin cancers in Japanese were detected by statistical analysis. Although the p21 polymorphisms were found not to be involved wit h skin carcinogenesis, ethnic differences of the allele frequency distribut ion must be taken into account in studying the role of the p21 polymorphism in carcinogenesis. (C) 2000 Elsevier Science Ireland Ltd. All rights reser ved.